[go: up one dir, main page]

GB201615282D0 - Tankyrase inhibitors - Google Patents

Tankyrase inhibitors

Info

Publication number
GB201615282D0
GB201615282D0 GBGB1615282.9A GB201615282A GB201615282D0 GB 201615282 D0 GB201615282 D0 GB 201615282D0 GB 201615282 A GB201615282 A GB 201615282A GB 201615282 D0 GB201615282 D0 GB 201615282D0
Authority
GB
United Kingdom
Prior art keywords
tankyrase inhibitors
tankyrase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1615282.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bath
Original Assignee
University of Bath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bath filed Critical University of Bath
Priority to GBGB1615282.9A priority Critical patent/GB201615282D0/en
Publication of GB201615282D0 publication Critical patent/GB201615282D0/en
Priority to PCT/GB2017/052624 priority patent/WO2018046933A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1615282.9A 2016-09-08 2016-09-08 Tankyrase inhibitors Ceased GB201615282D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1615282.9A GB201615282D0 (en) 2016-09-08 2016-09-08 Tankyrase inhibitors
PCT/GB2017/052624 WO2018046933A1 (en) 2016-09-08 2017-09-08 Tankyrase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1615282.9A GB201615282D0 (en) 2016-09-08 2016-09-08 Tankyrase inhibitors

Publications (1)

Publication Number Publication Date
GB201615282D0 true GB201615282D0 (en) 2016-10-26

Family

ID=57234618

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1615282.9A Ceased GB201615282D0 (en) 2016-09-08 2016-09-08 Tankyrase inhibitors

Country Status (2)

Country Link
GB (1) GB201615282D0 (en)
WO (1) WO2018046933A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
WO2019084060A1 (en) 2017-10-24 2019-05-02 Silverback Therapeutics, Inc. Conjugates and methods of use thereof for selective delivery of immune-modulatory agents
TWI813611B (en) 2017-12-21 2023-09-01 美商律幫治療股份有限公司 Quinazolinones as parp14 inhibitors
US10751339B2 (en) 2018-01-20 2020-08-25 Sunshine Lake Pharma Co., Ltd. Substituted aminopyrimidine compounds and methods of use
EP4132914A4 (en) 2020-04-06 2024-04-03 The Regents of the University of California COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION
US11753413B2 (en) 2020-06-19 2023-09-12 Incyte Corporation Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
WO2021257857A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Naphthyridinone compounds as jak2 v617f inhibitors
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
CA3188639A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
WO2022046989A1 (en) 2020-08-27 2022-03-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
CN112375066B (en) * 2020-09-30 2022-05-27 大连理工大学 1, 8-naphthalic anhydride derivatives containing 8- (benzoylamino) quinoline and synthesis and application thereof
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
EP4298099A1 (en) 2021-02-25 2024-01-03 Incyte Corporation Spirocyclic lactams as jak2 v617f inhibitors
JP2025509672A (en) 2022-03-17 2025-04-11 インサイト・コーポレイション Tricyclic urea compounds as JAK2 V617F inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9505749B2 (en) * 2012-08-29 2016-11-29 Amgen Inc. Quinazolinone compounds and derivatives thereof
JP6423875B2 (en) * 2013-07-31 2018-11-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Oxoquinazolinyl-butanamide derivatives
JP6456392B2 (en) * 2013-09-11 2019-01-23 インスティチュート オブ キャンサー リサーチ：ロイヤル キャンサー ホスピタル 3-Aryl-5-substituted isoquinolin-1-one compounds and therapeutic uses thereof

Also Published As

Publication number Publication date
WO2018046933A1 (en) 2018-03-15

Similar Documents

Publication Publication Date Title
IL321844A (en) Inhibitors of the menin-mll interaction
IL287113A (en) Smyd inhibitors
IL259560A (en) Inhibitors of the menin-mll interaction
IL255006A0 (en) Bromodomain inhibitors
IL261586B (en) Bdii-selective bromodomain inhibitor
IL251784A0 (en) Bromodomain inhibitors
GB201615282D0 (en) Tankyrase inhibitors
SG11201802665VA (en) Ferroportin inhibitors
IL248895A0 (en) Phosphatidylinositol -kinase inhibitors
ZA201907136B (en) Ip6k inhibitors
IL265139B (en) Dopamine-b-hydroxylase inhibitors
DK3398277T3 (en) Random access-procedure
GB201612860D0 (en) Inhibitors
ZA201707186B (en) Bromodomain inhibitor
IL254916B (en) Inhibitors and their uses
GB201501004D0 (en) Inhibitors
IL274550A (en) Dopamine-b-hydroxylase inhibitors
EP3201181A4 (en) Sphingosine kinase inhibitors
GB201520949D0 (en) Inhibitors
IL247025A0 (en) Enzyme inhibitors
GB201721465D0 (en) Inhibitors
ZA201807614B (en) Bromodomain inhibitors
GB201720189D0 (en) Dopamine-B-hydroxylase inhibitors
GB201614783D0 (en) Kinases inhibitors
HK40017687A (en) Dopamine-b-hydroxylase inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)